TOP STORIES

• REGULATORY Drug Costs Biggest Driver of Healthcare Spending Surge: Chuikyo JMA Rep
  September 29, 2016

• BUSINESS Tokyo Startup’s Osteoarthritis Drug Hopeful on Tap for PIb Launch by Year-End
  September 28, 2016

• REGULATORY Clinical Research Bill Set to Sail through Extra Diet with Opposition Backing
  September 27, 2016

• TRENDS Japan’s Established Drug Market Shines as Renewed Opportunity for Foreign Generic Firms
  September 26, 2016

• REGULATORY Pharma, Govt Hold 1st Kanmin Taiwa Working Group Talks; Industry Calls for Trial-Friendly Environment, Discussions on Pricing
  September 23, 2016

• BUSINESS Nichi-Iko to Set up Biosimilar Dept. in October to Push Remicade Follow-On
  September 21, 2016

• BUSINESS Eisai Looks to Achieve CAGR of 55% for Fycompa with Add’l Indications
  September 20, 2016

• REGULATORY As Personal Info Law Amendment Looms, Govt Official Tells Drug Makers to Review Info in Hand
  September 16, 2016

• REGULATORY Industry Chiefs, Chuikyo Panelists Trade Barbs over Market Expansion on Add’l Indications
  September 15, 2016

• BUSINESS Novartis Eager to See More 1st Approvals in Japan despite Pricing Headache
  September 14, 2016

• REGULATORY Blue Book “Will Be Used as Reference When Selecting Generics”: Panel Chair
  September 14, 2016

• REGULATORY G7 Health Ministers Adopt Kobe Communique
  September 13, 2016

• REGULATORY Generics from 5 Companies Enough When Major Products Lose Patent Protection: Top Bureaucrat
  September 13, 2016

• BUSINESS Nippon Shinyaku on Track to Achieve Targets in Midterm Plan with Sales of Selexipag Above Expectations: President
  September 12, 2016

• REGULATORY MHLW Panel Backs BI’s Triple Combo After 3rd Try
  September 9, 2016

• BUSINESS Biogen Japan’s Hemophilia Spinoff to Be Up and Running in Early 2017
  September 8, 2016

• ORGANIZATION Kenporen’s Kono Pushes for “Huge Seller” Re-Pricing for Opdivo before 2018
  September 7, 2016

• REGULATORY 6 National Centers Log Generic Use Rate of Average 73.8% in FY2015
  September 6, 2016

• BUSINESS Oncolys to Evaluate Oncolytic Virus in Combination with Immune Checkpoint Inhibitors; Interim Results Expected in 2017
  September 5, 2016

• BUSINESS Otsuka, RIKEN Open Collaborative Research Center to Promote Regenerative Medicine
  September 2, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 174
• 175
• 176
• 177
• 178
• 179
• 180
• 181
• 182
• …
• Next ›
• 最終 »